Literature DB >> 28447408

Flow cytometry-Recognizing unusual populations in leukemia and lymphoma diagnosis.

M Keeney1, B D Hedley1, I H Chin-Yee1,2.   

Abstract

Flow cytometry is an invaluable technology in the examination of blood, bone marrow, tissue and body fluids for the presence or absence of hematological disease. It is used in both diagnostic and follow-up testing, with an increasingly important role in the detection of very small residual disease populations (Minimal Residual Disease, MRD) However, flow cytometry immunophenotyping of leukemia and lymphoma is highly dependent on interpretation of results and with the increased complexity of 8-10 color instruments routinely used in clinical laboratories, knowledge of disease-defining populations is increasingly important as is recognizing normal and reactive patterns. This manuscript presents case studies with flow cytometric patterns encountered in routine screening of samples sent for leukemia and lymphoma immunophenotyping, focusing mainly on B-cell disorders which may be missed or incorrectly interpreted by the laboratory (including a hematopathologist) performing the test. Case studies are used to illustrate our laboratory's standardized approach to the interpretation of flow cytometric data. In addition to a standardized approach, these cases emphasize the importance of interpretative skills of technologist and hematopathologists in recognizing abnormal patterns in detecting hematological malignancies.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  CD45 negative; Flow Cytometry; PNH; case studies

Mesh:

Year:  2017        PMID: 28447408     DOI: 10.1111/ijlh.12666

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  2 in total

1.  OMIP - 081: A new 21-monoclonal antibody 10-color panel for diagnostic polychromatic immunophenotyping.

Authors:  Erik H L P G Huys; Willemijn Hobo; Frank W M B Preijers
Journal:  Cytometry A       Date:  2021-11-01       Impact factor: 4.714

Review 2.  Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma.

Authors:  Raquel Vinhas; Rita Mendes; Alexandra R Fernandes; Pedro V Baptista
Journal:  Front Bioeng Biotechnol       Date:  2017-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.